Central alpha-adrenergic agonist antihypertensive drugs and renal failure
Campanacci, L.; Bellini, G.; Battilana, G.; Rigoni, A.; Cosenzi, A.; Carretta, R.; Puppis, E.; Pierini, B.; Faccini, L.
La Clinica Terapeutica 109(4): 301-309
1984
ISSN/ISBN: 0009-9074 PMID: 6236023 Document Number: 240847
Document emailed within 1 workday
Related Documents
van Zwieten, P.A. 1973: The central action of antihypertensive drugs, mediated via central alpha-receptors Journal of Pharmacy and Pharmacology 25(2): 89-95Quintin, L.; Ghignone, M.; Pujol, J.F. 1987: The ability of the alpha 2-adrenergic agonist clonidine to suppress central noradrenergic hyperactivity secondary to hemodynamic or environmental stimuli Journal of Cardiovascular Pharmacology 10(Suppl 12): S128-S134
Buccafusco, J.J.; Lapp, C.A.; Westbrooks, K.L.; Ernsberger, P. 1995: Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 273(3): 1162-1171
Bousquet, P.; Feldman, J.; Schwartz, J. 1984: Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines Journal of Pharmacology and Experimental Therapeutics 230(1): 232-236
Jacob, B.G.; Richter, W.O.; Schwandt, P. 1993: Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators Fortschritte der Medizin 111(8): 126-129
DiBona, G.F. 1984: Central nervous system-renal interrelationship in mechanism of action of guanabenz: role of peripheral alpha 2-adrenoceptor agonist activity Journal of Cardiovascular Pharmacology 6(Suppl 3): S543-S544
Bergström, G.; Evans, R.G. 1998: Effects of renal medullary infusion of a vasopressin V1 agonist on renal antihypertensive mechanisms in rabbits American Journal of Physiology 275(1): R76-R85
Saran, R.K.; Ahuja, R.C.; Gupta, N.N. 1980: Paradoxical use of an alpha adrenoceptor agonist (methoxamine) an an antihypertensive Journal of the Association of Physicians of India 28(1-2): 39-43
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51
Cooper, B.; Handin, R.I.; Young, L.H.; Alexander, R.W. 1978: Agonist regulation of the human platelet alpha-adrenergic receptor Nature 274(5672): 703-706
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Bell, C.C. 1983: Simultaneous treatment of hypertension and opiate withdrawal using an alpha 2-adrenergic agonist Journal of the National Medical Association 75(1): 89-93
McClelland, D.L.; Rosenkranz, R.P. 1991: Antihypertensive, sympatholytic and renal effects of an orally active dopamine agonist, RS-12254 Proceedings of the Western Pharmacology Society 34: 135-140
Ishikawa, K.; Kakegawa, T.; Suzuki, M. 1986: Plasma thyrotrophin (TSH) response to intrahypothalamic injection of an alpha 2-adrenergic receptor agonist (clonidine) Acta Endocrinologica 111(1): 25-29
Tsai, B.S.; Lefkowitz, R.J. 1979: Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets Molecular Pharmacology 16(1): 61-68
Christ, G.J.; Brink, P.R.; Zhao, W.; Moss, J.; Gondré, C.M.; Roy, C.; Spray, D.C. 1993: Gap junctions modulate tissue contractility and alpha 1 adrenergic agonist efficacy in isolated rat aorta Journal of Pharmacology and Experimental Therapeutics 266(2): 1054-1065
Jagadeesh, G.; Deth, R.C. 1988: Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes Journal of Pharmacology and Experimental Therapeutics 247(1): 196-202
Skuza, G.; Kolasiewicz, W. 2001: Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. a behavioral study Polish Journal of Pharmacology 53(5): 547-550
Tsai, B.S.; Lefkowitz, R.J. 1978: Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets Molecular Pharmacology 14(4): 540-548
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142